According to the report of the World Health Organization (WHO), there are very few antibiotics in the development and research pipeline to reach the burgeoning antibiotic resistance challenge. Although, the pipeline contains several dozens of the antibiotics, many of them are still in the phase of modifications and some are “likely to cover a broader range of resistant pathogens.” The report was published on Tuesday by WHO, warning that world may run out of the effective antibiotics very soon.
The researchers reported that, most of the scientists are continuously busy in developing the new drug compounds based on the antibiotics, which are already exists in the market. But, many of these existing drugs are less efficient because of the bacteria that used to be resistant to those drugs slowly. Very few
Tedros Adhanom, a Director-General of WHO said in the press release that, “Antimicrobial resistance is a global health emergency that will seriously jeopardize progress in modern medicine. There is an urgent need for more investment in research and development for antibiotic resistant infections, including TB. Otherwise we will be forced back to a time when people feared common infections and risked their lives from minor surgery.”
As reported by the WHO Global Tuberculosis Programme Director, Mario Raviglione, the research has been underfunded seriously since long period of time for tuberculosis. Since, there are only two recent antibiotics have reached on the market for the treatment of drug resistant tuberculosis in over 70 years.
Mario Raviglione said that, “If we are to end tuberculosis, more than US$ 800 million per year is urgently needed to fund research for new anti-tuberculosis medicines”.